|
 Alzheimer's Disease
 Merz - our research for your health. Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist.
Alzheimer's Disease: learn more about the different forms of diseases, current research, drugs, treatment, therapies and care. Alzheimer's Disease is a topic that anyone of us should think about, because when growing old, everyone could be affected. Inform yourself about Alzheimer's Disease now! The care for elderly people and their diseases are a topic for our society, whose importance grows each day. That's why we at Merz take Alzheimer's Disease very serious, so that we can offer you the best drug for each treatment and therapy you need. Alzheimer's Disease and Merz means research for your health. High-quality products and information about Alzheimer's Disease can be found on our website. Visit us online and learn everything about Alzheimer's Disease from one of Germany's leading health care companies. Our contribution to Alzheimer's Disease: read here what we can do for you. Further links: Axura: Information for professionals.>>
Alzheimer's Disease is a topic that anyone of us should think about, because when growing old, everyone could be affected.
Memantine , Alzheimer's Treatment . Calcium enters into the cell, and through secondary processes, the signal is recognized. Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Senile Dementia , Dementia Care . As memantine, in contrast to magnesium, blocks the NMDA receptor in the presence of sustained release of low glutamate concentrations, the influx of calcium is prevented (neuroprotection). A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Alzheimer's Research , Alzheimer . At the same time, Memantine reduces caregiver time by more than 50 hours a month. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Demenzkranke , Verwirrtheit Gedächtnisstörungen Short Term Memory Loss Symptoms Of Alzheimer's Disease . If you have questions regarding Memantine, Axura or Namenda, please contact the responsible department. Alzheimer Erkrankung , Symptoms Of Alzheimer's Alzheimer's Disease Symptoms . In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Alzheimer's Drug Dementia Symptoms , Hirnleistungsstörungen . Other franchise covered by Merz are hepatology, metabolic diseases and dermatology. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Demenz Krankheit Alzheimer Behandlung NMDA-Schutz Demenz Früherkennung , Mild Cognitive Impairment Altersdemenz . At the same time, Memantine reduces caregiver time by more than 50 hours a month. The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Other franchise covered by Merz are hepatology, metabolic diseases and dermatology. At the same time, Memantine reduces caregiver time by more than 50 hours a month. This is clearly discernible behind the low background noise. During physiological learning and memory processes, high concentrations of synaptic glutamate are transiently released. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. The safety of the combination therapy was investigated in a postmarketing surveillance study. Alzheimer und Demenz , Glutamate Demenz Behandlung Demenz-Erkrankung . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Alzheimer's Disease Alzheimer Therapie , Symptoms Of Dementia . NMDA-Antagonist Forgetfulness , Glutamat Alzheimer Früherkennung . The excitatory effect of chronically released glutamate effects the degeneration of cortical and subcortical neurons, thus leading to the occurrence of dementia symptoms. Merz is a leader in the field of Alzheimer research and developed the first drug for the treatment of moderate to severe Alzheimer s. vaskuläre Demenz , Lewy Body Dementia Demenz Therapie Vascular Dementia . In contrast to first generation therapies, Memantine is likely to show neuroprotective effects at concentrations used in the treatment of Alzheimer s disease and to slow down disease progression. Gedächtnis , Demenz . Merz , Multi Infarct Dementia . Alzheimer's Dementia Axura , Vergesslichkeit Antidementiva Alzheimer's Caregiver . However, due to the already elevated calcium concentration, the signal can no longer be detected (occurrence of dementia symptoms). The intracellular calcium pool is reduced, and the noise lower. Stages Of Alzheimer's Disease , Akatinol Alzheimer's Support Hirnleistungsstörung NMDA-Protection . Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. As memantine, in contrast to magnesium, blocks the NMDA receptor in the presence of sustained release of low glutamate concentrations, the influx of calcium is prevented (neuroprotection). Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Alzheimer's , Demenzerkrankung Dementia . Memory Loss Pseudodemenz Alzheimer's Care , Dementia Treatment . Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist. Dementia And Alzheimer's Alzheimer Krankheit , Demenzkrank . Alzheimer's Symptoms , Mental Confusion . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. Dementia Medication Literatur , Erkennung Diagnose Studien . However, due to the already elevated calcium concentration, the signal can no longer be detected (occurrence of dementia symptoms). Memantine is well tolerated even in long-term therapy. Memantine is well tolerated even in long-term therapy. Medikamentkombinationen , Demenz Medikament . Therapy , Help . Diagnosis , Information Literature . The 2 large studies have shown positive effects of memantine in mild to moderate cases of vascular dementia. Studies , Combination . Treatment Alzheimer's Therapie Demenz Alzheimer Medikament , Medication Alzheimer's .
 Alzheimer's Disease
|
